ADHD in girls and boys – gender differences in co-existing symptoms and executive function measures by Skogli, Erik Winther et al.
 ADHD in girls and boys – gender differences in co-existing
symptoms and executive function measures
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Skogli, Erik Winther, Martin H Teicher, Per Normann Andersen,
Kjell Tore Hovik, and Merete Øie. 2013. “ADHD in girls and
boys – gender differences in co-existing symptoms and
executive function measures.” BMC Psychiatry 13 (1): 298.
doi:10.1186/1471-244X-13-298. http://dx.doi.org/10.1186/1471-
244X-13-298.
Published Version doi:10.1186/1471-244X-13-298
Accessed February 19, 2015 2:50:08 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879090
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Skogli et al. BMC Psychiatry 2013, 13:298
http://www.biomedcentral.com/1471-244X/13/298RESEARCH ARTICLE Open AccessADHD in girls and boys – gender differences in
co-existing symptoms and executive function
measures
Erik Winther Skogli1*, Martin H Teicher2, Per Normann Andersen1, Kjell Tore Hovik1 and Merete Øie1,3Abstract
Background: ADHD is diagnosed and treated more often in males than in females. Research on gender differences
suggests that girls may be consistently underidentified and underdiagnosed because of differences in the expression
of the disorder among boys and girls. One aim of the present study was to assess in a clinical sample of medication
naïve boys and girls with ADHD, whether there were significant gender x diagnosis interactions in co-existing symptom
severity and executive function (EF) impairment. The second aim was to delineate specific symptom ratings and
measures of EF that were most important in distinguishing ADHD from healthy controls (HC) of the same gender.
Methods: Thirty-seven females with ADHD, 43 males with ADHD, 18 HC females and 32 HC males between 8 and
17 years were included. Co-existing symptoms were assessed with self-report scales and parent ratings. EF was
assessed with parent ratings of executive skills in everyday situations (BRIEF), and neuropsychological tests. The
three measurement domains (co-existing symptoms, BRIEF, neuropsychological EF tests) were investigated using
analysis of variance (ANOVA) and random forest classification.
Results: ANOVAs revealed only one significant diagnosis x gender interaction, with higher rates of self-reported
anxiety symptoms in females with ADHD. Random forest classification indicated that co-existing symptom ratings
was substantially better in distinguishing subjects with ADHD from HC in females (93% accuracy) than in males
(86% accuracy). The most important distinguishing variable was self-reported anxiety in females, and parent ratings
of rule breaking in males. Parent ratings of EF skills were better in distinguishing subjects with ADHD from HC in
males (96% accuracy) than in females (92% accuracy). Neuropsychological EF tests had only a modest ability to
categorize subjects as ADHD or HC in males (73% accuracy) and females (79% accuracy).
Conclusions: Our findings emphasize the combination of self-report and parent rating scales for the identification
of different comorbid symptom expression in boys and girls already diagnosed with ADHD. Self-report scales may
increase awareness of internalizing problems particularly salient in females with ADHD.
Keywords: ADHD, Gender, Comorbidity, Executive functions, BRIEFBackground
Attention-deficit/hyperactivity disorder (ADHD) is one of
the most common childhood neuropsychiatric disorders,
characterized by problems with inattention, hyperactivity
and impulsivity [1]. Worldwide prevalence estimates for
childhood ADHD range between 3% and 7% [1] with a
male-to-female ratio of 3:1 in population based studies* Correspondence: erik.skogli@sykehuset-innlandet.no
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reproduction in any medium, provided the or[2,3] and between 5:1 to 9:1 in clinical samples [1,3,4].
Research on gender differences suggests that girls may be
consistently underidentified and underdiagnosed mostly
explained by differences in the expression of the disorder
among boys and girls [3,5-7]. Females with ADHD are
reported to have fewer hyperactive/impulsive symptoms
and more inattentive symptoms when compared with males
with ADHD [3,8,9]. Further, females with ADHD present
more commonly with the inattentive subtype than do boys
[10]. Less disruptive behavior in females with ADHD may
contribute to referral bias causing underidentification andtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ample, Sciutto, Nolfi, & Bluhm [12] found that teachers
more often refer boys than girls for treatment for
ADHD, even when showing equal levels of impairment.
Another major contributing factor to late or missed
diagnoses in females appears to be the presence of co-
existing symptoms that often cloud the diagnostic picture
[5]. As many as 75% of children with ADHD are likely to
have at least one other psychiatric disorder [2,13]. Thus, in
clinical practice, co-existing psychiatric problems are the
rule rather than the exception. Boys with ADHD have been
found to have more externalizing disorders than normal
developing boys, while females tend to show more intern-
alizing disorders in comparison to normal developing girls
[3,5,9]. In addition, adolescent females with ADHD are
reported to show more internalizing symptoms than their
male counterparts [14]. Often other diagnoses are made
long before the diagnosis of ADHD is assessed in female
clinical populations because of less overt ADHD symptoms
[15]. By comparison, more overt acting out behavior seems
to drive referral for ADHD assessment in boys [3].
With regard to executive functions (EF), which are con-
sidered a central source of the disability associated with
ADHD [16-19], previous research has yielded more simi-
larities than differences between girls and boys with ADHD
[11,20]. Despite the centrality of EF deficits in ADHD, a
neuropsychological profile distinct to females with ADHD
when compared with male counterparts has yet to be iden-
tified. In addition, neuropsychological tests have shown to
be weakly related to the severity of ADHD symptoms [21],
and recent studies suggest that many subjects with ADHD
perform normally on EF tests [22,23]. Where traditional
neuropsychological EF tests seem to capture “best esti-
mates” in an ideal setting [24], the Behavior Rating Inven-
tory of Executive Function (BRIEF) was designed to assess
EF performance in ecologically valid situations [25]. This
instrument has shown consistent, but modest correlations
with neuropsychological EF tests [26-28]. The BRIEF has
proven to be a valuable additional assessment tool for the
identification of ADHD in school-aged children [28,29],
demonstrating better sensitivity than neuropsychological
EF tests [28]. To the best of our knowledge, no studies have
investigated potential gender effects on BRIEF in children
and adolescents with ADHD. However, Huizinga and col-
leagues [30] reported elevated levels of executive problems
assessed with BRIEF in normal developing boys compared
to normal developing girls (age range 5–18 years). These
findings are comparable to the data presented in the ori-
ginal version of the BRIEF, showing superior performance
in girls compared to boys in general [25].
In sum, the gender gap in clinical populations of subjects
with ADHD continues to hamper the correct diagnosis
and treatment of females with ADHD. To our knowledge,
the current study is the first to include both self-report andparent ratings of co-existing symptoms in addition to
laboratory testing and inventory based scales assessing EF
in medication naïve boys and girls with ADHD to examine
potential gender sensitive ADHD profiles.
Our first aim was to assess whether there were significant
gender x diagnosis interactions in co-existing symptom
severity and EF impairment. Using conventional ANOVAs
we hypothesised that boys and girls with ADHD would
show greater impairment in all three measurement domains
(co-existing symptoms, neuropsychological EF tests, BRIEF)
relative to HC. However, we expected to find few significant
gender x diagnosis interactions in the three measurement
domains. Our second aim was to delineate specific symp-
tom ratings and measures of EF that were most important
in distinguishing ADHD from HC in the same gender. We
used random forest classification with cross-validation,
where the identification of subtle differences across diag-
nosis and gender in moderately sized samples is possible.
It was hypothesised that co-existing internalizing symp-
toms would better distinguish subjects with ADHD from
HC in females than in males. Co-existing externalizing
symptoms would better distinguish subjects with ADHD
from HC in males than in females. Second, neuropsycho-
logical test results were expected to distinguish subjects
with ADHD from HC equally well in males and females.
Finally, parent ratings of EF were hypothesised to better
distinguish subjects with ADHD from HC in males than
in females.
Methods
Procedure and participants
Demographic characteristics are presented in Table 1. Forty
three males with ADHD (M = 11.2 years), 37 females with
ADHD (M = 11.9 years), 32 healthy control (HC) males
(M = 11.4 years) and 18 HC females (M = 11.9 years) be-
tween 8 and 17 years participated in the study. The
ADHD participants were recruited as consecutive referrals
from seven outpatient Child and Adolescent Mental Health
Centres in Innlandet Hospital Trust (IHT) for assessment
of ADHD. All participants underwent a comprehensive
assessment according to common clinical practice. Semi-
structured clinical interviews (Kiddie-Schedule for Affective
Disorders and Schizophrenia - K-SADS) [31] were con-
ducted separately for children/adolescents and parents to
assess psychopathology. The interviewers were experienced
clinicians, and were trained to high levels of interrater
reliability for the assessment of diagnosis. The diagnostic
evaluation with K-SADS was supplemented with informa-
tion from the ADHD Rating Scale IV (ARS-IV) [32], and
the Child Behavior Checklist/6-18 [33], which covers the
DSM-IV symptoms for ADHD. Teacher reports describing
school functioning, both academic and socially, which
is mandatory on referral, were incorporated into the
diagnostic evaluation. Diagnoses were considered positive
Table 1 Demographic characteristics: means and standard deviations within the four groups
ADHD Healthy controls
Variable Boys1 (n = 43) Girls2 (n = 37) Boys3 (n = 32) Girls4 (n = 18) Group comparison Bonferroni*
F P
Age (months) 139.2 (23.2) 149.4 (25.1) 141.5 (22.6) 148.5 (27.3) F (3,126) = 1.50 NS
Mother’s education (yrs) 12.6 (2.3) 12.9 (1.9) 14.6 (2.5) 14.6 (2.1) F (3,126) = 6.80 < .001 1 < 3,4; 2 < 3
FSIQ (WASI)a) 94.3 (13.2) 96.4 (15.5) 101.9 (12.7) 107.1 (13.1) F (3,126) = 4.60 = .004 1,2 < 4
Inattentionb) 16.6 (5.8) 15.0 (5.6) 1.8 (2.1) 1.4 (1.6) F(3,125) = 95.50 < .001 1,2 < 3,4
Hyperactivity/Impulsivityc) 10.2 (6.5) 10.1 (6.7) 1.1 (1.3) 0.8 (1.4) F (3,125) = 30.86 < .001 1,2 < 3,4
CGASd) 56.0 (8.4) 59.3 (9.3) t (78) = 2.82 NS
a)Full Scale IQ.
b)ADHD rating scale – IV.
c)ADHD rating scale – IV.
d)Children Global Assessment Scale.
*1 = ADHD Boys, 2 = ADHD Girls, 3 = HC Boys, 4 = HC Girls.
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teacher information and rating scales, DSM-IV [1] criteria
were met.
Based on diagnostic evaluation with K-SADS, co-existing
diagnoses within the group of males with ADHD included
depression (4.7%), anxiety (4.7%), conduct disorder (4.7%),
and oppositional defiant disorder (11.6%). Co-existing
diagnoses within the females with ADHD included anxiety
(8.1%), and oppositional defiant disorder (10.8%). Despite
a low prevalence of co-existing diagnoses, parent and self-
report scales indicated elevated levels of externalizing and
internalizing symptoms in both males and females with
ADHD when compared with normal developing counter-
parts. Exclusion criteria for all participants included pre-
maturity (< 36 weeks), IQ below 70, a history of stimulant
treatment or any disease affecting the central nervous
system. None of the participants used any type of psycho-
pharmacological medication. One boy with ADHD was ex-
cluded due to estimated IQ below 70. None were excluded
due to history of stimulant treatment or any disease affect-
ing the central nervous system.
All participants in the HC groups were screened for
mental disorders with the K-SADS in separate interviews
for children/adolescents and parents. The HC were re-
cruited from local schools and were given a small com-
pensation for participating. The HC could not have been
treated for a mental disorder, have a psychiatric diagnosis,
have had a head injury (with loss of consciousness) or
known dyslexia. The four groups (ADHD/females, ADHD/
males, HC/females, HC/males) did not differ significantly
with regard to age and gender distribution. The Wechsler
Abbreviated Scale of Intelligence (WASI) [34] was adminis-
tered to estimate IQ in all participants. The groups differed
significantly with regard to IQ, F (3,126) = 4.60, p = .004,
Eta2 = .099, and Bonferroni post-hoc analysis showed that
both ADHD gender groups scored below the females in
the HC group. On average, mothers of children in the HCgroup had 1.7 years more education than mothers of chil-
dren with ADHD, F (3,126) = 6.80, p < 0.001. All par-
ents/caregivers and participants above 12 years gave
written informed consent in accordance with the Research
Ethics Committee in Eastern Norway. All children under
the age of 12 years provided oral consent to participate.
The study was approved by the Regional Committee for
Medical Research Ethics in Eastern Norway (REK-Øst),
and by the Privacy protection ombudsman for research at
Innlandet Hospital Trust. It was conducted in accordance
with the Helsinki Declaration of the World Medical Asso-
ciation Assembly.Measures
Measures of symptomatology
The Child Behavior Checklist/6-18 (CBCL) [33] is a widely
used scale containing 7 competence items and 113 specific
problem items, each of which is rated on a 0–2 metric.
The 120 items assess adaptive behavior as well as eight
narrow band factors (Anxious/Depressed, Withdrawn/De-
pressed, Somatic Complaints, Social Problems, Thought
Problems, Attention Problems, Rule-Breaking Behavior and
Aggressive Behavior) and two broadband factors (External-
izing and Internalizing symptoms) of co-existing symptoms.
The 2001 revision also includes seven DSM-oriented
scales consistent with DSM diagnostic categories (Affective
Problems, Anxiety Problems, Somatic Problems, ADHD,
Oppositional Defiant Problems and Conduct Problems).
On the parent-report CBCL, we used seven of the narrow
band factors (excluding Attention Problems) and five of
the DSM-oriented scales (excluding ADHD) to assess
co-existing symptoms. Elevated T-scores indicate a higher
degree of co-existing internalizing and externalizing symp-
toms. Cross-cultural studies have demonstrated good
discriminant validity with mean factor loadings across
societies at .62 [35]. Acceptable reliability and validity
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Nøvik [36,37].
The Revised Children’s Manifest Anxiety Scale, second
edition (RCMAS-2) [38] is a 49-item self-report instrument
designed to measure anxiety symptoms in children 6 to
19 years of age. Children respond either “Yes” or “No” to
all 49-items. The instrument reveals three anxiety factors:
Physiological Anxiety, Worry and Social Anxiety. The three
anxiety factors are summed yielding a Total Anxiety score.
Elevated raw-scores indicate a higher degree of anxiety
symptoms. The RCMAS Total Anxiety Scale has been
found to have satisfactory psychometric properties with
high test–retest reliability [39,40] and consistent construct
validity [41-44]. Satisfactory psychometric properties have
been replicated among other cultures as well [39,45-47].
The State-Trait Anxiety Inventory for Children (STAIC)
[48] includes two 20-item self-report scales that measure
both enduring tendencies (Trait) and situational variations
(State) in levels of perceived anxiety. Children respond
on a three-point scale indicating varying degree of worry,
feelings of tension, and/or nervousness. Elevated raw-scores
indicate a higher degree of situational and temporal anxiety.
In a quantitative review by Seligman and colleagues [49],
the authors argue that the STAIC possess satisfactory
psychometric properties.
The Short Mood and Feelings Questionnaire (SMFQ)
[50] is a 13-item self-report instrument designed to meas-
ure depressive symptoms in children 8 to 18 years of age.
The SMFQ is derived from the original 30-item Mood and
Feelings Questionnaire (MFQ) [51] where children respond
on a three-point scale (“not true”, “sometimes true” and
“true”). A net score was generated based on the 13 items
with elevated raw-scores indicating a higher degree of
depression symptoms. The SMFQ have demonstrated
high internal consistency (Crohnbach’s alpha = .90) [52],
and test-retest stability in children for a two-week period
yielded an intra class correlation of .66 [51]. Angold and
colleagues [50] found SMFQ to correlate strongly with
Children’s Depression Inventory (CDI) [53] and Diagnostic
Interview Schedule for Children (DISC-C) depression
scores [51] (r = .67 and .51, respectively).Neuropsychological EF tests
The letter-number sequencing test
The Letter-Number Sequencing Test (LN) [54] was used
as a measure of working memory. The test consists of
ten items. Each item contains three trials with the same
number of digits and letters. The test administrator reads
aloud each trial and asks the child to recall the numbers
in ascending order and the letters in alphabetical order.
In the present study, total correct recalled trials were
examined. Lower scaled scores indicated difficulties with
the task.The colour - word interference test, condition 3
The Colour - Word Interference Test, Condition 3 (CW 3)
[55,56] was used as a measure of inhibition. The examinee
needs to inhibit an overlearned verbal response when
naming the dissonant ink colours in which the words are
printed. For the present study, completion time in seconds
was examined. Lower scaled scores indicated difficulties
with the task.
The colour - word interference test, condition 4
The Colour - Word Interference Test, Condition 4 (CW 4)
[56] was used as a measure of cognitive flexibility. The
examinee is asked to switch back and forth between
naming the dissonant ink colours and reading the words.
For the present study, completion time in seconds was
examined. Lower scaled scores indicated difficulties with
the task.
The trail making test, condition 4
The Trail Making Test, condition 4 (TMT 4) [56] was used
as a measure of cognitive flexibility. The examinee is asked
to draw a line interchangeably between numbers and letters
in the right order. For the present study, time to complete
task was examined. Lower scaled scores indicated difficul-
ties with the task.
The design fluency test, condition 3
The Design Fluency Test, condition 3 (DF) [56] was used
as a measure of cognitive flexibility. The examinee is asked
to draw as many different designs as possible using
four straight lines connecting five filled and empty dots
interchangeably. The examinee is given 60 seconds for
the task. For the present study, total correct responses
were examined. Lower scaled scores indicated difficulties
with the task.
The tower test
The Tower Test [56] was used as a measure of planning.
In this task the examinee is asked to construct several
target towers by moving five disks, varying in size, across
three pegs in the fewest number of moves possible. While
doing this, the examinee is allowed to move only one
disk at a time, and not to place a larger disk over a smaller
disk. In the present study total achievement score was
examined. Lower scaled scores indicated difficulties with
the task.
The letter fluency test
The Letter Fluency Test (LF) [56] was used as a measure of
verbal fluency. This task includes three 60-seconds trials,
where participants were asked to generate words fluently
in an effortful, phonemic format with the letters F, A, and
S. For the present study, total correct responses were
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Inventory based information of EF
The BRIEF for children and adolescents aged 5 to 18
includes a parent form and a teacher form [25]. In the
current study, the Norwegian parent rating version was
used. The BRIEF is composed of eight clinical scales
(Inhibition, Shift, Emotional Control, Initiate, Working
Memory, Plan/Organize, Organization of Materials and
Monitor). Fallmyr & Egeland [57] reported high internal
consistency (Chronbachs α = .76-.92) on the Norwegian
parent rating version of the BRIEF. These values are at
the same level as Chronbachs α reported in the BRIEF
manual (.80-.98) [25]. Elevated BRIEF T-scores indicate
a higher degree of impairment.
Data analyses
Data analyses were conducted using the statistical pack-
age SPSS for Windows, version 15.0 (SPSS, Inc., Chicago,
IL). Demographic characteristics were investigated using
the Chi-square test for independence (nominal variables)
and analysis of variance (ANOVA) (continuous variables)
followed up by Bonferroni post-hoc tests for group com-
parisons when adequate. ANOVAs were carried out to
investigate gender x diagnosis interactions in the three
measurement domains (co-existing symptoms, neuro-
psychological EF tests, BRIEF).
Random forest classification
In addition to tests of significance we also used an algorith-
mic modelling/data mining technique to explore gender
differences in co-existing symptoms and EF ratings and
measures. Classical statistical techniques are designed to
test and reject the hypothesis that observed differences
between groups have occurred by chance. Algorithmic
modelling techniques have been developed to address a
somewhat different question. Briefly, these techniques
can identify from a sample of potential predictor variables
the most important subset for categorizing subjects or
predicting outcomes [58]. Hence, we used this approach
to delineate within each gender the subset of symptom
ratings, EF measures and EF ratings that appear to be
most important in discriminating children with ADHD
from HC. Specifically, we used random forest classification
and cross-validation (R packages randomForest 4.5-34 and
caret 5.02-011) [59] to identify and rank order different
symptom ratings and EF measures for their degree of
importance in differentiating ADHD from HC within each
gender. Although importance and statistical significance
often go hand-in-hand, the two are not necessarily the
same. The approach has many advantages. In particular, it
can provide meaningful results with smaller sample sizes
than stochastic models. Further they are less susceptibleto overfitting and multicollinearity, provide more accurate
predictions, and do not make the unlikely assumption
that the multivariate data being analyzed are multivariate
normal.
Briefly, this is a form of “ensemble learning” in which a
large number of unpruned decision trees are generated
and their results aggregated [60]. The random part comes
in as each tree is constructed using a different bootstrap
sample of the data, and each node is split using the best
among a subset of predictors randomly chosen at that
node. As Liaw and Wiener indicate [61] this strategy
performs very well compared to many other classifiers,
including discriminant analysis, logistic regression, support
vector machines and neural networks [60]. It is primarily
used in data mining and in genomic analysis, such as
microarray studies.
Each decision tree was generated using results from
75% of the participants and then tested on the remaining
25% (validation set). This process was performed 5000
times on different random splits of the data to provide a
cross-validated estimate of the predictive discriminant
ability of the measures (accuracy, kappa) that would
likely generalize to new cases [62]. The importance of
each variable in the cluster was assessed by calculating the
decrease in predictive accuracy following the sequential
permutation (effective randomization and elimination) of
each variable in the cluster on the validation set. The most
important variables were the ones whose effective elimin-
ation from the forest produced the greatest degradation in
accuracy.
Results
The first statistical approach tested the hypothesis that
there were significant gender x diagnosis interactions across
the array of dependent variables (DVs), viewing each of the
DVs in isolation. In the second approach we evaluated the
ability of ratings or measures in the: (1) symptom (CBCL,
RCMAS-2, STAIC, SMFQ), (2) EF test performance, and
(3) EF rating (BRIEF) clusters to predict whether partici-
pants met criteria for ADHD, and if the most important
predictor variables in each cluster were the same for males
and females.
As seen in Table 2 there were marked group differences
between participants with ADHD and HC in symptom
ratings. In general, there was a roughly parallel increase
in symptom ratings with diagnosis across gender, and the
only significant diagnosis x gender interaction was observed
in ratings of physiological anxiety on the RCMAS-2. There
were significant main effects of diagnosis on several of the
EF measures including: working memory (LN), inhibition
(CW3), and cognitive flexibility (CW4, TMT4, DF). How-
ever, there were no significant gender x diagnosis interac-
tions on these measures (Table 3). Interestingly, there were
also robust group differences between parent ratings of
Table 2 Group differences and interaction effects on symptom ratings (ANOVA): means and standard deviations
Group Main and interaction effects
ADHD Healthy controls
Boys (n = 43) Girls (n = 37) Boys (n = 32) Girls (n = 18) Group Gender Group X Gender
F p F p F p
CBCLa)
Anxious/depressed 58.3 (8.2) 61.1 (10.6) 51.5 (4.0) 51.4 (2.7) 31.11 <.001 1.52 NS 0.98 NS
Withdrawn/depressed 59.4 (8.2) 58.7 (7.2) 51.5 (2.5) 51.2 (2.6) 45.29 <.001 0.26 NS 0.04 NS
Somatic complaints 59.6 (8.9) 59.7 (8.6) 53.0 (4.7) 51.4 (2.5) 29.25 <.001 0.30 NS 0.35 NS
Social problems 60.4 (9.2) 60.0 (7.4) 50.5 (1.5) 50.3 (0.5) 65.08 <.001 0.02 NS 0.00 NS
Thought problems 58.1 (8.8) 57.2 (7.7) 51.1 (2.1) 50.6 (1.5) 31.40 <.001 0.36 NS 0.02 NS
Rule-breaking 60.3 (8.6) 58.6 (8.0) 50.9 (2.6) 50.8 (2.5) 52.06 <.001 1.59 NS 0.52 NS
Aggressive behavior 61.8 (11.7) 61.5 (9.6) 50.9 (1.8) 50.7 (2.1) 47.81 <.001 0.03 NS 0.00 NS
Affective problems 61.8 (8.7) 63.2 (8.8) 51.4 (3.6) 50.9 (1.7) 72.89 <.001 0.27 NS 0.47 NS
Anxiety problems 57.0 (7.8) 60.7 (8.4) 51.2 (3.4) 51.2 (3.3) 35.13 <.001 4.08 .045 2.21 NS
Somatic problems 60.0 (8.6) 60.1 (10.3) 53.4 (5.0) 51.6 (2.9) 25.96 <.001 0.17 NS 0.43 NS
Oppositional problems 59.7 (8.4) 59.8 (8.3) 51.3 (2.2) 51.5 (2.7) 45.75 <.001 0.00 NS 0.00 NS
Conduct problems 62.6 (9.8) 60.1 (8.3) 51.2 (2.6) 50.9 (2.4) 61.60 <.001 2.18 NS 0.80 NS
SMFQb) 6.3 (4.9) 7.7 (4.9) 2.4 (2.8) 1.7 (1.6) 38.83 <.001 0.70 NS 1.91 NS
RCMAS-2c)
Physiological anxiety 5.1 (2.2) 6.5 (2.3) 2.6 (2.2) 1.4 (1.6) 82.35 <.001 1.61 NS 10.46 .002
Worry 4.2 (4.0) 6.3 (3.8) 2.1 (1.8) 2.0 (1.9) 25.06 <.001 4.83 .030 3.40 NS
Social anxiety 3.6 (3.2) 5.4 (2.7) 1.3 (1.6) 1.4 (1.7) 39.42 <.001 5.94 .016 2.95 NS
STAICd)
State 29.2 (4.1) 30.1 (5.0) 27.3 (4.0) 27.4 (3.4) 8.21 .005 0.23 NS 0.16 NS
Trait 30.5 (8.5) 34.4 (7.9) 27.7 (5.2) 26.5 (5.9) 13.42 <.001 2.39 NS 3.67 NS
a)The Child Behavior Checklist/6-18 (df = 1,124). b)The Short Mood and Feelings Questionnaire (df = 1,123). c)The Revised Children’s Manifest Anxiety Scale, second
edition (df = 1,124). d)The State-Trait Anxiety Inventory for Children: State (df = 1,121), Trait (df = 1,122).
Note. Higher scores denote greater pathology.
Table 3 Group differences and interaction effects on executive function measures (ANOVA): means and standard
deviations
Group Main and interaction effects
ADHD Healthy controls
Boys (n = 43) Girls (n = 37) Boys (n = 32) Girls (n = 18) Group Gender Group X Gender
F p F p F p
LNa) 8.2 (2.9) 8.6 (2.6) 10.6 (1.5) 10.9 (1.7) 29.39 <.001 0.85 NS 0.01 NS
TMT4b) 7.1 (3.2) 7.8 (3.3) 9.3 (2.9) 10.2 (2.5) 17.14 <.001 2.24 NS 0.00 NS
CW3c) 8.4 (3.3) 8.3 (3.4) 10.0 (2.4) 11.5 (1.7) 17.40 <.001 1.11 NS 2.17 NS
CW4d) 7.9 (2.9) 7.1 (3.5) 10.0 (2.6) 10.9 (1.6) 28.46 <.001 0.07 NS 2.76 NS
Towere) 9.9 (2.2) 10.6 (2.3) 11.0 (2.1) 10.3 (1.7) 1.93 NS 0.13 NS 3.26 NS
DFf) 8.2 (2.5) 9.8 (3.8) 11.8 (2.9) 12.3 (2.4) 31.51 <.001 4.82 .030 0.83 NS
LFg) 8.2 (0.5) 9.1 (0.3) 11.3 (0.5) 11.8 (0.9) 26.21 <.001 1.53 NS 0.06 NS
a)The Letter-Number Sequencing Test (df = 1,123). b)The Trail Making Test, condition 4 (df = 1,123). c)The Colour-Word Interference Test, condition 3 (df = 1,125).
d)The Colour-Word Interference Test, condition 4 (df = 1,125). e)The Tower Test (df = 1,124). f)The Design Fluency Test, condition 3 (df = 1,116). g)The Letter Fluency Test
(df = 1,123).
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However, on none of the BRIEF ratings were there signifi-
cant diagnosis by gender interactions.
Random forest classification investigating the relationship
between ADHD status and non-ADHD symptom cluster
had a predictive (i.e., cross-validated) diagnostic accuracy
of 0.860 ± 0.058 (mean ± SD) in males and 0.932 ± 0.055
in females. Kappa coefficients were 0.715 ± 0.115 and
0.844 ± 0.133 for males and females, respectively. This in-
dicates that random forest classification using non-ADHD
symptom ratings was substantially better at discriminating
female subjects with ADHD from female HC than they
were in discriminating males with ADHD from male HC
(accuracy: z = 5.8, p < 10-8; kappa: z = 4.7, p < 10-5; two-
sample Z-test). As seen in Figure 1, the rank order pattern
of variable importance for discriminating ADHD from HC
was similar in males and females (rs = 0.676, p < 0.003).
CBCL ratings of social problems and affective problems
were key distinguishing variables in both genders. However,
rule breaking was the most important distinguishing
variable in males, while physiological anxiety symptoms
on the RCMAS-2 was the most important distinguishing
variable in females.
Random forest classification investigating the relationship
between ADHD status and EF tests assessing: working
memory, inhibition, cognitive flexibility, planning, and
verbal fluency had only a modest ability to distinguish par-
ticipants with ADHD from HC (males: accuracy = 0.734 ±
0.078, kappa = 0.466 ± 0.152; females: accuracy = 0.785 ±
0.078, kappa = 0.507 ± 0.175). There was a significant
gender difference in the predictive ability of random forests
based on measures of accuracy but not kappa (accuracy:
z = 3.22, p < 0.001; kappa: z = 1.22, p < 0.12). As seen in
Figure 2, the rank order patterning of variable importanceTable 4 Group differences and interaction effects on executiv
deviations
Group
ADHD Health
Boys (n = 43) Girls (n = 37) Boys (n = 32
Inhibit 59.7 (15.9) 62.5 (12.9) 42.3 (3.5)
Shift 57.5 (13.7) 57.3 (11.3) 40.9 (5.8)
Emotional control 59.0 (14.1) 61.3 (13.7) 40.7 (3.7)
Initiate 59.2 (11.5) 61.8 (12.1) 41.0 (7.2)
Working memory 69.3 (9.9) 70.5 (10.1) 41.6 (4.9)
Plan/Organize 64.6 (9.8) 67.0 (10.3) 41.4 (5.3)
Organization of materials 56.7 (11.4) 58.3 (10.8) 41.3 (7.8)
Monitor 60.3 (11.9) 63.8 (12.3) 37.9 (6.1)
*df = 1,125.
Note: Elevated BRIEF T-scores indicate a higher degree of impairment, with T-scores
of concern.on these measures were not significantly correlated between
genders (rs = 0.143, p > 0.7). The most important distin-
guishing variables in males were performance on tests
assessing cognitive flexibility (DF) and verbal fluency
(LF). The most important distinguishing variables in fe-
males were performance on tests assessing working
memory (LN), inhibition (CW 3), and cognitive flexibility
(CW 4).
Random forest classification investigating the relationship
between ADHD status and BRIEF showed that parent rat-
ings of executive skills were able to discriminate males with
ADHD from male HC with high accuracy (0.960 ± 0.036,
kappa 0.916 ± 0.076). Random forest classification using
BRIEF items was not quite as accurate in discriminating
females with ADHD from female HC (accuracy = 0.923 ±
0.051, z = 4.29, p < 10-5 versus males; kappa = 0.818 ±
0.123, z = 4.85, p < 10-6). As seen in Figure 3, BRIEF work-
ing memory was the most important distinguishing variable
in both genders. However, the rank ordering of importance
of the eight BRIEF variables between genders correlated to
only a marginal degree (rs = 0.667, p = 0.07).
Discussion
As expected, results on non-ADHD symptom ratings, EF
ratings and EF measures differed substantially between
ADHD subjects and HC. Boys and girls with ADHD
showed in general greater impairment in all three measure-
ment domains relative to HC. There was little evidence for
diagnosis x gender differences in mean ratings or mea-
sures, with more self-reported physiological anxiety in
females with ADHD relative to the other groups, as the
only significant diagnosis x gender finding. Elevated levels
of co-existing internalizing symptoms in females with
ADHD relative male counterparts is in accordance withe function ratings (ANOVA): means and standard
Main and interaction effects
y controls
) Girls (n = 18) Group Gender Group X Gender
F* p F* p F* p
42.6 (3.3) 75.17 <.001 0.60 NS 0.31 NS
40.6 (3.1) 77.65 <.001 0.09 NS 0.00 NS
41.4 (5.3) 88.14 <.001 0.32 NS 0.12 NS
40.1 (5.8) 112.18 <.001 0.70 NS 0.96 NS
42.8 (4.1) 333.64 <.001 0.56 NS 0.00 NS
41.3 (4.1) 250.37 <.001 0.66 NS 0.60 NS
42.1 (7.4) 75.41 <.001 0.63 NS 0.06 NS
39.7 (4.5) 160.68 <.001 1.91 NS 0.17 NS
of 65 and above considered to represent clinically significant areas
Figure 1 Relative importance of symptoms ratings in predicting ADHD status by gender with random forest classification.
Figure 2 Relative importance of executive function measures in predicting ADHD status by gender with random forest classification.
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Figure 3 Relative importance of executive functions ratings (BRIEF) in predicting ADHD status by gender with random
forest classification.
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diagnosis x gender differences in general is consistent with
previous reports from population-based studies indicating
that the disorder is expressed similarly in boys and girls
[8,63]. On the other hand, random forest classification with
cross-validation provided evidence for meaningful gender
differences when investigating the relationship between
ADHD status and the three measurement clusters, and in
the relative importance of specific items.
First, random forest regression with cross-validation of
the symptom cluster indicated that non-ADHD symptoms
appeared to be better at categorizing participants as HC or
ADHD in females than in males. Our results corroborate
previous findings by Rucklidge & Tannock [14] reporting
that parent and teachers reported more difficulties with op-
positional behaviors, conduct problems, social difficulties,
anxiety, and depression in females with ADHD compared
to male counterparts. Together these findings provide
evidence that co-existing psychological impairment may
be even more reliably evident in females with ADHD
compared to HC females than in males with ADHD
relative to HC males.
Consistent with our hypothesis random forest regression
with cross-validation indicated that the most important
non-ADHD symptom for categorizing females as ADHD
or HC was increased self-reported physiological anxiety
(internalizing symptoms), whereas the most important
symptom in males was parent rated rule breaking (exter-
nalizing symptoms). Elevated ratings of somatic complaints
in girls with ADHD have previously been reported in
population based studies [64], and supports a hypothesis
of somatic complaints as markers for anxiety proneness in
females with ADHD [65,66]. Elevated levels of externalizingsymptoms in males with ADHD have been documented
in several research reviews [3,5,9].
Third, random forest regression with cross-validation
showed that neuropsychological measures of EF had only a
modest ability to categorize participants as ADHD or HC.
Differences in accuracy when categorizing participants as
HC or ADHD in females versus males were slight (79%
versus 73% accuracy), and were consistent with our hypoth-
esis of no major difference in discriminatory power between
genders. These results corroborate previous findings report-
ing moderate validity of EF tests for classifying children
with ADHD [18,23]. Interestingly, there were differences
between genders in the specific EF measures that appeared
to be the most important distinguishing variables. Cognitive
flexibility and verbal fluency were the most important
distinguishing variables in males, whereas working memory
and inhibition were the most important distinguishing
variables in females. A few previous studies have reported
sex differences in EF in children with ADHD [67,68]
though most studies report similar EF profiles [11,20]. In
sum, EF tests show limited sensitivity and specificity for
classifying boys and girls with ADHD.
Fourth, random forest regression with cross-validation
indicated that parental ratings of EF were relatively robust
distinguishing variables of ADHD status in this sample. In
line with our hypothesis, BRIEF scales was significantly
better at discriminating males with ADHD from HC males
than they were in discriminating females with ADHD from
female HC. While there were differences in the relative
importance of the different EF ratings, working memory
appeared to be the most important distinguishing variable
in both boys and girls. The sensitivity of working memory
ratings in distinguishing boys and girls with ADHD from
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[69] and McCandless & O’Laughlin [29]. Our results indi-
cating better discriminatory power in males than in females
with the BRIEF, suggests that ADHD in males may be
more reliably associated with impairments in EF than in
females. This higher risk of behavioral problems in males
with ADHD symptoms may be one reason for the referral
of more boys than girls for clinical evaluation of ADHD,
as previously suggested by Gaub and Carlson [3].
In our study, the participants’ symptoms were assessed
with both self-report and parent rating scales. Previous
research has shown that clinical samples of children often
report more symptoms about themselves than parents do
with regard to anxiety and depression [70-74]. In contrast,
parents are found to report more conduct disorders [72]
or behavioral symptoms than their children [75-77].
Our results with self-reported internalizing symptoms
(physiological anxiety) in females with ADHD and parent
rated functional impairment in males with ADHD reflect
previous reports regarding a self-report/parent rating
discrepancy. As internalizing symptoms are less readily
observed, parental reports of anxiety and depression
are less sensitive than parental reports of externalizing
behaviors [77]. It has been speculated that high levels of
anxiety and depression in females with ADHD indicate
that females are more negatively affected than their male
counterparts [78]. The inclusion of self-report scales in
clinical practice may thus increase awareness of internaliz-
ing problems particularly salient in females with ADHD,
and intervention should target co-existing anxiety and
depression when indicated. Where parent ratings seem
to be informative regarding behavioral problems in boys
with ADHD, self-report scales may be more informative
regarding internalizing problems in girls with this disorder.
Thus, clinical intervention should be sensitive to different
expression in co-existing symptoms for boys and girls with
ADHD, in addition to conventional treatment of ADHD
symptoms.
Strengths of the present study are inclusion of subjects
not medicated with psychopharmaca and no history of
stimulant treatment. Additional strengths are the use
of both self-report and parent ratings when assessing
co-existing symptoms, and laboratory tests and inventory-
based scales assessing EF. Further, random forest classifi-
cation [60] is a relatively novel method of determining
variable importance, with the advantages of very high
classification accuracy and no restrictions regarding the
distribution and scaling properties of the data [79]. These
properties make random forest regressions well-suited for
the classification of large sets of data. It is interesting in
this context that predictive modelling with random forests
identified gender differences in the accuracy of cluster
based categorizations and in the importance of specific
measures, whereas conventional statistical analyses showedonly one instance of a significant diagnosis by gender
interactions. This is basically a consequence of limited
power of the ANOVA test to detect small or subtle inter-
actions. Significant interactive effects are typically detected
when the opposite response pattern is seen across gender,
or when a large effect is present in one gender and a small
effect is present in the other. In order to detect a subtle
interactive effect (f = 0.1) with power of 0.8 would have
required a much larger sample size (n = 787).
We used random forests with cross-validation to simul-
taneously assess clusters of variables to delineate predictive
accuracy and to identify the most important distinguishing
variables. This approach has been shown to be effective
in identifying the most important predictors in large sets
of variables with fewer participants then can even be
considered using conventional statistical techniques [60].
For instance, this approach can be used in microarray
studies to accurately identify the most important subset of
polymorphisms even when the number of variables greatly
exceeds the number of participants. In short, this approach
makes it possible to identify subtle differences across
diagnosis and gender in symptom measures and ratings
in moderately sized samples.
The present findings need to be interpreted in the
context of some methodological limitations. Participants
were recruited from a sample of referred subjects, and
consequently are not necessarily representative of children
and adolescents with ADHD in the general population.
However, we believe the participants are fairly representa-
tive of males and females referred for the evaluation of
ADHD related symptoms. Previous findings have reported
that females with ADHD present more commonly with the
inattentive subtype than do boys [10]. These subtype ef-
fects may potentially have an impact on gender dependent
symptom profiles observed in our study. However, despite
an overload of males in the ADHD-C group (23 males, 13
females), subtype distribution did not differ significantly
by gender in our sample, and the level of inattention and
hyperactivity/impulsivity symptoms (ARS-IV) [32] was
equal between males and females with ADHD. Albeit
previous studies have reported gender differences in
hyperactive/impulsive and inattentive symptoms [3,8,9],
findings by Lambek and colleagues [80] indicated that these
gender dependent subtype effects may be more evident in
non-referred than in referred samples of boys and girls
with ADHD.
Conclusions
Overall, females with ADHD could be more accurately
distinguished from HC by the presence of co-existing
symptoms, particularly physiological components of anx-
iety. On the other hand, parental reports of EF impairments
were substantially better at distinguishing subjects with
ADHD from HC in males. Given the almost universal
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emphasize the combined value of self-report and parent
rating scales for the identification of comorbid symptoms
in boys and girls already diagnosed with ADHD.
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